Altered expression of brain related genes in lymphocytes in schizophrenia

- Bowden, N. A., Weidenhofer, J. C., Scott, R. J., Todd, J., Case, V., Schall, U., Tooney, P. A.

Gene profiling in the amygdala in schizophrenia

- Weidenhofer, J., Bowden, N. A., Scott, R. J., Tooney, P. A.

Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia

- Green, M. J., Cairns, M. J., Wu, J., Dragovic, M., Jablensky, A., Tooney, P. A., Scott, R. J., Carr, V. J.

Gray matter deficits, mismatch negativity, and outcomes in schizophrenia

- Rasser, P. E., Schall, U., Thompson, P. M., Todd, J., Michie, P. T., Ward, P. B., Johnston, P., Helmbold, K., Case, V., Soyland, A., Tooney, P. A.

Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells

- Gardiner, E., Beveridge, N. J., Wu, J. Q., Carr, V., Scott, R. J., Tooney, P. A., Cairns, M. J.

Schizophrenia is associated with an increase in cortical microRNA biogenesis

- Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A., Cairns, M. J.